Oral nicotine pouch use in Great Britain: a repeat cross-sectional study, 2020-25
Harry Tattan-Birch1, Sarah E Jackson1, Lion Shahab1
1Department of Behavioural Science and Health, University College London, London, UK.
Nicotine pouch use is rising in Great Britain, particularly among young men. Most users also consume other nicotine products, and pouches are increasingly used for smoking cessation attempts.
Area of Science:
- Public Health
- Nicotine Addiction Research
- Consumer Product Trends
Background:
- Global sales of oral nicotine pouches have surged recently.
- Population-level usage patterns for these products are not well-documented.
Purpose of the Study:
- To investigate recent trends in nicotine pouch consumption within Great Britain.
- To analyze demographic and behavioral factors associated with nicotine pouch use.
Main Methods:
- Utilized data from the Smoking Toolkit Study, a representative monthly survey (Oct 2020–Mar 2025).
- Included participants aged 16 and older, with nicotine pouch use self-reported.
- Analyzed trends in prevalence, sociodemographic stratification, and use for smoking cessation.
Main Results:
- Adult nicotine pouch use increased from 0.1% to 1.0% between Oct 2020 and Mar 2025.
- From 2022, usage surged among 16-24-year-olds (0.7% to 4.0%), especially young men.
- Most users (69%) also used other nicotine products; 56% smoked, 39% vaped.
- Use for smoking cessation attempts rose from 2.6% to 6.5% among quit attempters.
Conclusions:
- Nicotine pouch use is increasing in Great Britain, driven by youth uptake.
- Concurrent use with other nicotine products is common; increasing use for smoking cessation.
- Recommends age-of-sale legislation and further research on cessation effectiveness.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
